print share
Version HistoryVersion History


Collaborative Care for Opioid and Alcohol Use Disorders in Primary CareThe SUMMIT Randomized Clinical Trial (JAMA Internal Medicine)

Publication Topics

Other Conditions

Publication Type

External Publication

Publication Date


Author 1

<a onclick="OpenPopUpPage('{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1466&RootFolder=*', RefreshPage); return false;" href="{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1466&RootFolder=*">Katherine E. Watkins</a>

Author 2

<a onclick="OpenPopUpPage('{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1467&RootFolder=*', RefreshPage); return false;" href="{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1467&RootFolder=*">Allison J. Ober</a>

Author 3

<a onclick="OpenPopUpPage('{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1468&RootFolder=*', RefreshPage); return false;" href="{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=1468&RootFolder=*">Karen Lamp</a>

Author 4

<a onclick="OpenPopUpPage('{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=107&RootFolder=*', RefreshPage); return false;" href="{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=107&RootFolder=*">Allison L. Diamant, MD, MSHS</a>

Author 5

<a onclick="OpenPopUpPage('{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=151&RootFolder=*', RefreshPage); return false;" href="{7AAD61FA-4BCB-48C0-B0B7-87AFDC3673EF}&ID=151&RootFolder=*">et al</a>

Author 6

Author 7

Author 8

Author 9

Author 10

Author 11

Author 12

Author 13

Author 14


​A randomized clinical trial of 377 primary care patients with opioid and/or alcohol use disorders (OAUD) was conducted in 2 clinics in a federally qualified health center to determine whether collaborative care (CC) for OAUD improves delivery of evidence-based treatments for OAUD and increases self-reported abstinence compared with usual primary care. Collaborative care was a system-level intervention, designed to increase the delivery of either a 6-session brief psychotherapy treatment and/or medication-assisted treatment with either sublingual buprenorphine/naloxone for opioid use disorders or long-acting injectable naltrexone for alcohol use disorders. Usual care participants were told that the clinic provided OAUD treatment and given a number for appointment scheduling and list of community referrals.

After 6 months, the proportion of participants who received any OAUD treatment was higher in the CC group compared with usual care (39.0% vs. 16.8%); A higher proportion of CC participants reported abstinence from opioids or alcohol at 6 months (32.8% vs 22.3%). In secondary analyses, the proportion meeting the Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement measures was also higher among CC participants (initiation, 31.6% vs 13.7%; engagement, 15.5% vs 4.2%) as was abstinence from opioids, cocaine, methamphetamines, marijuana, and any alcohol (26.3% vs 15.6%). The study was conducted by the RAND.


Article 1

Collaborative Care for Opioid and Alcohol Use Disorders in Primary CareThe SUMMIT Randomized Clinical Trial

Article 2

Article 3

Article 4

Article 5

Article 6

Article 7

Article 8

Article 9

Article 10

Article 11

Article 12

Press Release

Related Link 1


Related Link 2

Related Link 3

Related Link 4

Related Link 5

Related Link 6

Related Link 7

Related Link 8

Related Link 9

Related Link 10

Related Link 11

Related Link 12

Related Link 13

Related Link 14

Related Link 15

Related Link 16

Version: 5.0
Created at 9/11/2017 12:28 PM by i:0#.f|uclachissqlmembershipprovider|venetia
Last modified at 9/11/2017 6:46 PM by i:0#.f|uclachissqlmembershipprovider|venetia